- Home
- INM vs EAD Comparison
INM vs EAD Comparison
Compare INM & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- EAD
- Stock Information
- Founded
- INM 1981
- EAD 2003
- Country
- INM Canada
- EAD United States
- Employees
- INM N/A
- EAD N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- EAD Finance/Investors Services
- Sector
- INM Health Care
- EAD Finance
- Exchange
- INM Nasdaq
- EAD Nasdaq
- Market Cap
- INM 3.2M
- EAD N/A
- IPO Year
- INM N/A
- EAD N/A
- Fundamental
- Price
- INM $2.98
- EAD $6.72
- Analyst Decision
- INM
- EAD
- Analyst Count
- INM 0
- EAD 0
- Target Price
- INM N/A
- EAD N/A
- AVG Volume (30 Days)
- INM 54.4K
- EAD 178.9K
- Earning Date
- INM 05-13-2025
- EAD 01-01-0001
- Dividend Yield
- INM N/A
- EAD 8.91%
- EPS Growth
- INM N/A
- EAD N/A
- EPS
- INM N/A
- EAD N/A
- Revenue
- INM $4,832,013.00
- EAD N/A
- Revenue This Year
- INM N/A
- EAD N/A
- Revenue Next Year
- INM N/A
- EAD N/A
- P/E Ratio
- INM N/A
- EAD N/A
- Revenue Growth
- INM N/A
- EAD N/A
- 52 Week Low
- INM $1.72
- EAD $5.69
- 52 Week High
- INM $15.70
- EAD $6.81
- Technical
- Relative Strength Index (RSI)
- INM 58.03
- EAD 56.22
- Support Level
- INM $2.85
- EAD $6.38
- Resistance Level
- INM $3.10
- EAD $6.67
- Average True Range (ATR)
- INM 0.25
- EAD 0.11
- MACD
- INM 0.06
- EAD 0.05
- Stochastic Oscillator
- INM 78.44
- EAD 100.00
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.